14.39
price down icon1.30%   -0.19
after-market After Hours: 14.39
loading
Elanco Animal Health Inc stock is traded at $14.39, with a volume of 4.08M. It is down -1.30% in the last 24 hours and up +0.70% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$14.58
Open:
$14.6
24h Volume:
4.08M
Relative Volume:
0.73
Market Cap:
$7.15B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
35.98
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-3.62%
1M Performance:
+0.70%
6M Performance:
+17.09%
1Y Performance:
+11.29%
1-Day Range:
Value
$14.28
$14.60
1-Week Range:
Value
$14.28
$15.14
52-Week Range:
Value
$8.02
$15.78

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Name
Elanco Animal Health Inc
Name
Phone
877-352-6261
Name
Address
2500 INNOVATION WAY, GREENFIELD
Name
Employee
9,450
Name
Twitter
@Elanco
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELAN's Discussions on Twitter

Compare ELAN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
14.39 7.24B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.01 67.12B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.32 45.19B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.81 43.57B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.93B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.56 13.45B 2.99B 1.21B 1.13B 25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-17-25 Upgrade Leerink Partners Market Perform → Outperform
Jun-26-25 Upgrade William Blair Mkt Perform → Outperform
Dec-09-24 Initiated UBS Buy
Dec-02-24 Initiated Leerink Partners Market Perform
Sep-19-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-05-24 Upgrade Stifel Hold → Buy
Dec-19-23 Initiated Jefferies Buy
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-23 Initiated Exane BNP Paribas Outperform
Apr-20-23 Upgrade Barclays Equal Weight → Overweight
Aug-18-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-16-22 Downgrade JP Morgan Overweight → Neutral
Jul-21-22 Downgrade Goldman Buy → Sell
Jul-12-22 Initiated Piper Sandler Neutral
Nov-18-21 Initiated Morgan Stanley Overweight
Oct-28-21 Downgrade Stifel Buy → Hold
Aug-05-21 Resumed Credit Suisse Outperform
Jun-15-21 Upgrade Cleveland Research Underperform → Neutral
May-11-21 Upgrade Barclays Underweight → Equal Weight
May-11-21 Upgrade Gabelli & Co Hold → Buy
Apr-15-21 Initiated Stifel Buy
Mar-22-21 Downgrade Gabelli & Co Buy → Hold
Feb-26-21 Upgrade Credit Suisse Neutral → Outperform
Dec-09-20 Downgrade Argus Buy → Hold
Nov-09-20 Downgrade Barclays Overweight → Underweight
Aug-20-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-13-20 Resumed Credit Suisse Neutral
Aug-04-20 Resumed Goldman Buy
Jul-27-20 Downgrade Cleveland Research Neutral → Underperform
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-10-20 Initiated Raymond James Mkt Perform
Dec-19-19 Upgrade BofA/Merrill Neutral → Buy
Nov-07-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-23-19 Initiated Barclays Overweight
Aug-26-19 Downgrade BofA/Merrill Buy → Neutral
Aug-15-19 Upgrade UBS Sell → Neutral
May-23-19 Initiated Guggenheim Neutral
Mar-18-19 Upgrade BofA/Merrill Neutral → Buy
Mar-13-19 Resumed Morgan Stanley Equal-Weight
Feb-12-19 Initiated William Blair Mkt Perform
Jan-23-19 Initiated UBS Sell
Jan-15-19 Initiated Argus Buy
Oct-15-18 Initiated Morgan Stanley Equal-Weight
View All

Elanco Animal Health Inc Stock (ELAN) Latest News

pulisher
06:56 AM

Sector Rotation Brings Elanco Animal Health Incorporated Into FocusMulti-Bagger Potential Stock Forecast Tools Released - beatles.ru

06:56 AM
pulisher
06:45 AM

Animal Growth Promoter Market Size and Share Forecast Outlook - openPR.com

06:45 AM
pulisher
06:30 AM

Fish Vaccine Market Generated Opportunities, Future Scope - openPR.com

06:30 AM
pulisher
04:30 AM

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Victory Capital Management Inc. - MarketBeat

04:30 AM
pulisher
01:22 AM

Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

01:22 AM
pulisher
12:42 PM

Allianz Asset Management GmbH Sells 317,192 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

12:42 PM
pulisher
Jul 28, 2025

European Commission approves Zenrelia - DVM360

Jul 28, 2025
pulisher
Jul 28, 2025

Wyckoff Accumulation Phase Possible in Elanco Animal Health IncorporatedEntry Points For Growing Stocks Identified by Models - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Dogs Vaccines Market to Witness Comprehensive Growth by 2032 | - openPR.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Elanco Animal Health IncorporatedLightning-fast capital gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Universal Beteiligungs und Servicegesellschaft mbH Invests $5.70 Million in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Does Elanco Animal Health Incorporated stock perform well during market downturnsBreakthrough profit margins - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Elanco Animal Health Incorporated stockExplosive trading growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Equitable Trust Co. Purchases 24,129 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jul 27, 2025
pulisher
Jul 27, 2025

Elanco Animal Health (NYSE:ELAN) Price Target Raised to $18.00 - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Private Management Group Inc. - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

Why Elanco (ELAN) Stock Is Trading Up Today - Yahoo Finance

Jul 25, 2025
pulisher
Jul 24, 2025

Elanco Animal Health Incorporated Stock Analysis and ForecastLightning-fast capital gains - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Elanco Animal Health Incorporated stock priceLightning-fast growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs - The Malaysian Reserve

Jul 24, 2025
pulisher
Jul 24, 2025

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs | ELAN Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

EU Approval Boosts Elanco (ELAN) with Zenrelia Milestone | ELAN Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Elanco Animal Health Incorporated stockDynamic portfolio growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

ELAN vs. USPH: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

Aquatic Veterinary Market Set to Witness Significant Growth - openPR.com

Jul 24, 2025
pulisher
Jul 24, 2025

Jennison Associates LLC Sells 329,115 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jul 24, 2025
pulisher
Jul 23, 2025

Elanco Animal Health (ELAN): UBS Maintains Buy Rating, Raises Pr - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Autogenous Vaccine for Aquaculture Market Generated - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

ELANCO SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Elanco Animal Health Inc. (NYSE:ELAN) And Encourages Long-Term Investors to Contact the FirmELAN - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 22, 2025

Is Elanco Animal Health Incorporated a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Are Medical Stocks Lagging Encompass Health (EHC) This Year? - Yahoo Finance

Jul 22, 2025
pulisher
Jul 21, 2025

Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

DDD Partners LLC Has $15.68 Million Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest

Jul 18, 2025

Elanco Animal Health Inc Stock (ELAN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$72.20
price down icon 0.29%
$9.19
price down icon 0.76%
drug_manufacturers_specialty_generic RDY
$14.76
price up icon 0.41%
$134.19
price up icon 0.36%
$297.56
price down icon 0.19%
Cap:     |  Volume (24h):